Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Germline Genetic Profiling Utilizing Multigene Panel Testing in Jordanian Patients with Pancreatic Cancer. A Comprehensive Cancer Center Experience2025
2. 2Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM2025
3. 3Selective germline testing in multiple myeloma patients yields a six-fold increase in actionable cancer predisposition findings: Time for screening guidelines?2025 · 1 citations
4. 4Retrospective review of clinical factors influencing germline testing in patients with pancreatic cancer across a hospital system between 2021–2023.2025
5. 5Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer2025